Basal lamina components at the neuromuscular junction

The basal lamina at the neuromuscular junction (NMJ) is a specialized extracellular matrix (ECM) that plays a pivotal role in synaptic structure and function (Sanes & Lichtman, 1999). It consists of a distinct set of proteins, including agrin, laminin isoforms (Laminin-211, 421, and 521), collagen IV, and perlecan, which differentiate it from the extrasynaptic basal lamina (Krakowski et al., 2015). A primary function of this structure is the organization of the postsynaptic apparatus, specifically the clustering of acetylcholine receptors (AChRs) mediated by nerve-derived agrin acting on the MuSK receptor (UniProt P56159). Furthermore, the synaptic basal lamina serves as a scaffold for acetylcholinesterase (AChE), which is anchored by the collagen-like tail protein ColQ to terminate synaptic transmission (UniProt Q9Y215). Defects in these components are linked to severe pathologies, such as congenital myasthenic syndromes (CMS) caused by ColQ or agrin mutations, and certain forms of muscular dystrophy (StatPearls, 2023). Therapeutic interventions often target these components, such as the use of AChE inhibitors like pyridostigmine to prolong the action of acetylcholine in the synaptic cleft (PubChem CID 4932). Understanding the molecular composition of the NMJ basal lamina is essential for developing treatments for autoimmune and genetic neuromuscular disorders.

Other names

Synaptic basal laminaNMJ extracellular matrixSynaptic ECM

Acetylcholinesterase inhibition, MuSK activation, and stabilization of the postsynaptic membrane.